ArticleThe journal of headache and pain2023

Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry.

Victor Obach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.